aTyr Pharma (NASDAQ: LIFE)
$5.34
(3.4%)
$0.18
Price as of August 28, 2025, 3:58 p.m. ET
aTyr Pharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
aTyr Pharma Company Info
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
News & Analysis
Featured Article
2 Small-Cap Biotech Stocks Well Positioned for a Breakout
Clinical trial results expected in the weeks ahead could push shares of these small-cap drugmakers through the roof.
Cory Renauer | Aug 27, 2025
Featured Article
1 Small-Cap Biotech Stock Poised for a Breakout
This developmental biotech is nearing a key inflection point.
George Budwell | Aug 6, 2025
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.